These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 9816098

  • 21. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.
    Zhao H, Zhang J, Lu J, He X, Chen C, Li X, Gong L, Bao G, Fu Q, Chen S, Lin W, Shi H, Ma J, Liu X, Ma Q, Yao L.
    BMC Cancer; 2008 Oct 22; 8():303. PubMed ID: 18940011
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.
    Devi GR, Oldenkamp JR, London CA, Iversen PL.
    Prostate; 2002 Nov 01; 53(3):200-10. PubMed ID: 12386920
    [Abstract] [Full Text] [Related]

  • 23. [Targeting delivery effect of galactose receptor-mediated c-myc antisense oligonucleotide on human hepatocellular carcinoma cell line Bel-7402].
    Jiang JW, Zhang Y.
    Ai Zheng; 2004 Nov 01; 23(11):1288-93. PubMed ID: 15522175
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA.
    Fujimoto K, Takahashi M.
    Biochem Biophys Res Commun; 1997 Dec 29; 241(3):775-81. PubMed ID: 9434785
    [Abstract] [Full Text] [Related]

  • 29. Induction of ETS-1 and ETS-2 transcription factors is required for thyroid cell transformation.
    de Nigris F, Mega T, Berger N, Barone MV, Santoro M, Viglietto G, Verde P, Fusco A.
    Cancer Res; 2001 Mar 01; 61(5):2267-75. PubMed ID: 11280797
    [Abstract] [Full Text] [Related]

  • 30. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
    Dellas A, Schultheiss E, Leivas MR, Moch H, Torhorst J.
    Anticancer Res; 1998 Mar 01; 18(6A):3991-8. PubMed ID: 9891436
    [Abstract] [Full Text] [Related]

  • 31. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
    Ginobbi P, Geiser TA, Ombres D, Citro G.
    Anticancer Res; 1997 Mar 01; 17(1A):29-35. PubMed ID: 9066627
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Combination antigene therapy targeting c-myc and c-erbB(2) in the ovarian cancer COC(1) cell line.
    Fei R, Shaoyang L.
    Gynecol Oncol; 2002 Apr 01; 85(1):40-4. PubMed ID: 11925118
    [Abstract] [Full Text] [Related]

  • 37. Effect of Bcl-2 antisense oligonucleotide on drug-sensitivity in association with apoptosis in undifferentiated thyroid carcinoma.
    Kim R, Tanabe K, Uchida Y, Emi M, Toge T.
    Int J Mol Med; 2003 Jun 01; 11(6):799-804. PubMed ID: 12736725
    [Abstract] [Full Text] [Related]

  • 38. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
    Chen H, Liu J, Zhao CQ, Diwan BA, Merrick BA, Waalkes MP.
    Toxicol Appl Pharmacol; 2001 Sep 15; 175(3):260-8. PubMed ID: 11559025
    [Abstract] [Full Text] [Related]

  • 39. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
    Kim Y, Yoon JW, Xiao X, Dean NM, Monia BP, Marcusson EG.
    Cancer Res; 2007 Apr 15; 67(8):3583-93. PubMed ID: 17440069
    [Abstract] [Full Text] [Related]

  • 40. Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells.
    Barr LF, Campbell SE, Bochner BS, Dang CV.
    Cancer Res; 1998 Dec 01; 58(23):5537-45. PubMed ID: 9850091
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.